Left Atrial Appendage (LAA) Closure Devices Market
Theglobal left atrial appendage (LAA) closure devices marketis anticipated to reachUSD 958 Millionby 2025, while augmenting at a significantCAGR 19.8％在预测期间。市场的增长归因于LAA封闭装置的心房颤动和技术进步的普遍存在。此外，在全球各地的最小侵入性疗法和生长的人口上升以及对LAA器件的认识增加，促进了对预测期内的市场需求的有利举措和越来越高的政府举措。然而，LAA设备的高成本可能会在一定程度上妨碍行业增长。
LAA closure device is the implantable cardiac devices which are designed to place in the left atrial appendage. The devices have potential to influence the clinical approach to stroke prevention in patients with atrial fibrillation.
Key findings from the report:
- Theglobal left atrial appendage (LAA) closure devices marketis expected to reachUSD 958 Million到2025年CAGR 19.8％during 2019-2025
- On the basis of product, the endocardial LAA closure devices segment held the major share of the market in 2018
- 在最终用户的基础上，医院实验室在2018年举行了市场的主要份额
- Geographically, North America held the major share of the global market in 2018
- Some of the key companies operating in the market include Abbott; AtriCure, Inc.; Boston Scientific Corporation; Lifetech Scientific; SentreHEART, Inc.; Cardia, Inc.; Occlutech International AB; Lepu Medical Technology (Beijing) Co., Ltd.; and Aegis Medical., among others
左心房附属（LAA）封闭设备：市场洞察力
Atrial fibrillation is a common significant cardiac arrhythmia, affecting approximately 33 million individuals worldwide. It is associated with a substantially higher risk of thromboembolism, particularly stroke events, resulting in significant morbidity and mortality across the globe. Additionally, more than 9% of people over 65 suffer from atrial fibrillation, irregular heartbeat that can lead to clot the blood, stroke, heart failure, and other heart-related complications. Moreover, surgical treatment of the left atrial appendage has increased over the past few years. The left atrial appendage closure devices are treatment strategy to reduce the risk of left atrial appendage blood clots from entering the bloodstream.
Browse full research report with TOC on“Global Left Atrial Appendage (LAA) Closure Devices Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025” at://www.sofiapartner.com/global-left-atrial-appendage-laa-closure-devices-market-report/
To purchase report:sales@energiasmarketresearch.com
Left Atrial Appendage (LAA) Closure Devices Market – Regional insight
Geographically, North America held the largest share of the market in 2018. The growth in the region is attributed to the rising prevalence of cardiovascular disorders, growing awareness among people, and growing government initiative. In the United States, it is estimated that 2.2 million people are affected from atrial fibrillation. Moreover, growing adoption of LAA closure device, favorable reimbursement environment, and growing development in LAA closure devices are further augmenting the market growth in the United States. However, Asia-Pacific region is expected to witness highest CAGR during the 2019-2025.
This report segments global left atrial appendage (LAA) closure devices market based on product, end-user and region.
By Product
- Endocardial LAA Closure Devices
- Epicardial LAA Closure Devices
By End-User
- 门诊手术中心
- Hospitals
- 其他
By Region
- North America
- Europe
- Asia-Pacific
- Central & South America
- 中东和非洲（MEA）
左心房阑尾关闭设备市场;促使产业生长的心房颤动的普遍存在